OAR 333-116-0220: Labeling of Vials and Syringes
Edition: Current OARD snapshotEffective: 2018-01-30Last verified: 2026-09-07
Each syringe and vial that contains unsealed byproduct material must be labeled to identify the radiopharmaceutical drug. Each syringe shield and vial shield must also be labeled unless the label on the syringe or vial is visible when shielded. The label must include the radiopharmaceutical name or abbreviation, the type of diagnostic study or therapy procedure to be performed and the patient's name.
Official history and status
Statutory/Other Authority: ORS 453.635
Statutes/Other Implemented: ORS 453.605 - 453.807
History: PH 12-2018, minor correction filed 01/30/2018, effective 01/30/2018 PH 10-2011, f. 9-30-11, cert. ef. 10-1-11 PH 4-2007, f. & cert. ef. 3-1-07 PH 12-2006, f. & cert. ef. 6-16-06 HD 1-1991, f. & cert. ef. 1-8-91
This rule cites
No citations extracted.
Cited by
No inbound citations found.
Official source: https://secure.sos.state.or.us/oard/